DK1423126T3 - Behandling af hyperproliferative lidelser på kropsoverflader - Google Patents

Behandling af hyperproliferative lidelser på kropsoverflader

Info

Publication number
DK1423126T3
DK1423126T3 DK02754556T DK02754556T DK1423126T3 DK 1423126 T3 DK1423126 T3 DK 1423126T3 DK 02754556 T DK02754556 T DK 02754556T DK 02754556 T DK02754556 T DK 02754556T DK 1423126 T3 DK1423126 T3 DK 1423126T3
Authority
DK
Denmark
Prior art keywords
treatment
body surfaces
hyperproliferative disorders
psoriasis
relates
Prior art date
Application number
DK02754556T
Other languages
Danish (da)
English (en)
Inventor
Thomas Broe Christensen
Bjarne Bymose
Original Assignee
Valderm Aps
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Valderm Aps filed Critical Valderm Aps
Application granted granted Critical
Publication of DK1423126T3 publication Critical patent/DK1423126T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/351—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom not condensed with another ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/02—Nasal agents, e.g. decongestants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/02—Drugs for genital or sexual disorders; Contraceptives for disorders of the vagina
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/08—Antiseborrheics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/12—Keratolytics, e.g. wart or anti-corn preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/16—Emollients or protectives, e.g. against radiation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Pulmonology (AREA)
  • Reproductive Health (AREA)
  • Endocrinology (AREA)
  • Otolaryngology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Gynecology & Obstetrics (AREA)
  • Toxicology (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Steroid Compounds (AREA)
  • Farming Of Fish And Shellfish (AREA)
  • Treatments Of Macromolecular Shaped Articles (AREA)
DK02754556T 2001-08-14 2002-08-12 Behandling af hyperproliferative lidelser på kropsoverflader DK1423126T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DKPA200101218 2001-08-14
PCT/DK2002/000530 WO2003015759A2 (en) 2001-08-14 2002-08-12 Treatment of hyperproliferative conditions of body surfaces

Publications (1)

Publication Number Publication Date
DK1423126T3 true DK1423126T3 (da) 2008-02-04

Family

ID=8160668

Family Applications (1)

Application Number Title Priority Date Filing Date
DK02754556T DK1423126T3 (da) 2001-08-14 2002-08-12 Behandling af hyperproliferative lidelser på kropsoverflader

Country Status (13)

Country Link
US (2) US7345023B2 (ja)
EP (1) EP1423126B1 (ja)
JP (1) JP4361789B2 (ja)
AT (1) ATE371458T1 (ja)
AU (1) AU2002320964B2 (ja)
CY (1) CY1107814T1 (ja)
DE (1) DE60222144T2 (ja)
DK (1) DK1423126T3 (ja)
ES (1) ES2292789T3 (ja)
NZ (1) NZ531408A (ja)
PT (1) PT1423126E (ja)
SI (1) SI1423126T1 (ja)
WO (1) WO2003015759A2 (ja)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2011006504A2 (en) 2009-07-17 2011-01-20 Valderm Aps Treatment of hyperproliferative conditions
WO2013026454A1 (en) 2011-08-22 2013-02-28 Valderm Aps Treatment of clinical conditions with anthracyclines
JP6659735B2 (ja) 2015-07-10 2020-03-04 インフェクトファーム・アルツナイミッテル・ウント・コンシリウム・ゲゼルシャフト・ミト・ベシュレンクテル・ハフツング 日光角化症の治療における水酸化カリウムの使用
CN108098458B (zh) * 2017-08-09 2019-12-24 徐先顺 一种用于抗hpv6/11的凝胶剂

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5149710A (en) * 1985-04-01 1992-09-22 National Research Development Corporation Pharmaceutical compositions for treating psoriasis
US4739046A (en) * 1985-08-19 1988-04-19 Luzio Nicholas R Di Soluble phosphorylated glucan
US4946683A (en) * 1987-11-18 1990-08-07 Vestar, Inc. Multiple step entrapment/loading procedure for preparing lipophilic drug-containing liposomes
AU3554089A (en) * 1988-04-27 1989-11-24 Yale University Compositions and methods for treating cutaneous hyperproliferative disorders
US6231855B1 (en) * 1991-03-12 2001-05-15 Istituto Nazionale Per Lo Studio E La Cura Dei Tumori Monoclonal antibodies as antidotes for anthracycline antibiotics
JP3251735B2 (ja) * 1992-09-25 2002-01-28 株式会社東芝 半導体集積回路装置
US5396195A (en) * 1993-12-13 1995-03-07 At&T Corp. Low-power-dissipation CMOS oscillator circuits
US6190691B1 (en) * 1994-04-12 2001-02-20 Adolor Corporation Methods for treating inflammatory conditions
US5900763A (en) * 1994-10-11 1999-05-04 Motorola, Inc. Circuit and method of reducing cross-talk in an integrated circuit substrate
ES2227536T3 (es) * 1995-06-27 2005-04-01 Pharmachemie B.V. Nuevos profarmacos de antraciclina, procedimiento de preparacion asi como su uso en quimioterapia selectiva.
DE19720312A1 (de) * 1997-05-15 1998-11-19 Hoechst Ag Zubereitung mit erhöhter in vivo Verträglichkeit
US5776915A (en) * 1997-08-12 1998-07-07 Clarion Pharmaceuticals Inc. Phosphocholines of retinoids
AU3764099A (en) 1998-04-28 1999-11-16 Tao Chen Polyanionic polymers which enhance fusogenicity
CA2331620A1 (en) 1998-05-11 1999-11-18 The Endowment For Research In Human Biology, Inc. Use of neomycin for treating angiogenesis-related diseases
AU778910B2 (en) * 1999-03-19 2004-12-23 Houston Pharmaceuticals, Inc. Methods and compositions for the manufacture of C-3' and C-4' anthracycline antibiotics
JP2001345428A (ja) * 2000-03-27 2001-12-14 Toshiba Corp 半導体装置とその製造方法
US6555095B1 (en) * 2001-12-14 2003-04-29 Avon Products, Inc. Topical compositions and methods of application

Also Published As

Publication number Publication date
SI1423126T1 (sl) 2008-02-29
EP1423126B1 (en) 2007-08-29
ES2292789T3 (es) 2008-03-16
DE60222144D1 (de) 2007-10-11
US7345023B2 (en) 2008-03-18
US20040242507A1 (en) 2004-12-02
US8263567B2 (en) 2012-09-11
WO2003015759A2 (en) 2003-02-27
DE60222144T2 (de) 2008-05-15
EP1423126A2 (en) 2004-06-02
JP2005504765A (ja) 2005-02-17
NZ531408A (en) 2005-07-29
JP4361789B2 (ja) 2009-11-11
US20080119546A1 (en) 2008-05-22
ATE371458T1 (de) 2007-09-15
CY1107814T1 (el) 2013-06-19
WO2003015759A3 (en) 2004-03-04
AU2002320964B2 (en) 2008-03-13
PT1423126E (pt) 2007-12-07

Similar Documents

Publication Publication Date Title
CY1106628T1 (el) Τοπικες φαρμακευτικες συνθεσεις περιλαμβανουσες προανθοκυανιδινες, γλυκυρροχητινικο οξυ και τελμεστεϊνη για τη θεραπεια των δερματιτιδων
WO2003018619A3 (en) Antimicrobial and anti-inflammatory peptides
WO2003055878A8 (de) 2-heteroarylcarbonsäureamide
LTC1620113I2 (lt) Ivermektino topinė kompozicija, skirta dermatologinių susirgimų gydymui
BR9915553A (pt) Amidas de ácido antranìlico e seu emprego como medicamento
BRPI0407662A (pt) derivados do ácido 1-fenilalcanocarboxìlico para o tratamento de doenças neurodegenerativas
NO20024005D0 (no) Pteridinforbindelser for behandling av psoriasis
DOP2002000429A (es) Imidazotriazinas
BR0306922A (pt) N-pirazinil-fenilsulfonamidas e seu uso no tratamento de doenças mediadas por quimocina
CY1108932T1 (el) Ενωσεις 4-(ετεροκυκλυλ)-βενζολοσουλφοξιμινης για την θεραπευτικη αγωγη φλεγμονωδων ασθενειων
TR200400228T4 (tr) Psöryazinin tedavisinde kullanılacak maddeler
EE05357B1 (et) Tablett, mis sisaldab v„hemalt kahte eristatavat segmenti, ning selle kasutamine
CY1107814T1 (el) Θεραπεια παθησεων υπερπολλαπλασιασμου των επιφανειων του σωματος
DE60229235D1 (de) D kupfersulfaten und sucralphat
ATE256392T1 (de) Verwendung von polyaminosäurederivate als konservierungsmittel
TR200000907T2 (tr) Nötrofil elastaz inhibitörleri olarak pirolopirolon türevleri.
BRPI0511125A (pt) usos de ácido 5,6,7-triidroxieptanóico seus e análogos
EA200500326A1 (ru) Применение ферментированного экстракта проростков пшеницы в качестве противовоспалительного агента
SV2003001061A (es) Nuevos heterociclos 3 ref.lea 35361-sv
AR030945A1 (es) Amidas de acido fenilciclohexanocarboxilico sustituido y su uso
DOP2002000472A (es) Amidas de acido piperazinciclohexanocarboxilico sustituidas y su utilizacion.
WO2002070537A3 (en) Fusidic acid derivatives
ATE241640T1 (de) Fusidinsäure-derivate
HUP0402624A2 (hu) Vírusgátlás n-dokozanollal
DOP2001000245A (es) Amidas de acido fenilciclohexanocarboxilico sustituido y su uso.